Lipid rafts and caveolae play a pivotal role in organization of signaling by TLR4 and several other immune receptors. Beyond the simple cataloguing of signaling events compartmentalized by these membrane microdomains, recent studies have revealed the surprisingly central importance of dynamic remodeling of membrane lipid domains to immune signaling. Simple interventions upon membrane lipid, such as changes in cholesterol loading or crosslinking of raft lipids, are sufficient to induce micrometer-scale reordering of membranes and their protein cargo with consequent signal transduction. In this review, using TLR signaling in the macrophage as a central focus, we discuss emerging evidence that environmental and genetic perturbations of membrane lipid regulate protein signaling, illustrate how homeostatic flow of cholesterol and other lipids through rafts regulates the innate immune response, and highlight recent attempts to harness these insights toward therapeutic development.

Since the inception of the lipid raft hypothesis in 1997 (1), a profusion of studies have reported roles for these cholesterol-enriched membrane microdomains in organization of cell signaling. As a crossroads for immunology, biophysics, and lipid science, the raft field has suffered growing pains in terminology, technique, and interpretation. Progressively refined imaging techniques continue to support the existence of lateral protein/lipid heterogeneities in biological membranes (2, 3), but the precise nature, size, and malleability of these microdomains remain a matter of debate. A burgeoning field that has cataloged an increasing number of signaling events within rafts at the same time finds itself at risk of losing sight of the implications of this localization. In this review, rather than focus on definitions of rafts/caveolae (for this, the reader is referred to recent scholarly reviews in Refs. 2, 4, 5), the objective is to synthesize and interpret emerging insights on how genetic and environmental modification of raft lipid plays a fundamental role in determining immune signaling and disease. The case will be made that dynamic remodeling of raft lipid is not only necessary in many signaling cascades, but that primary perturbations of raft lipid (e.g., cholesterol loading or unloading, raft coalescence) can also be sufficient initiating events to trigger protein signaling. Using the macrophage and, in particular, TLR signaling in macrophages as a primary case in point, the dependence of inflammatory signaling upon cholesterol-loading conditions and on the regulatory proteins that control homeostatic intracellular trafficking of cholesterol through rafts will be highlighted.

Lipid rafts are thought to be highly dynamic, nanoscale (i.e., <200 nm), cholesterol- and sphingolipid-enriched membrane microdomains, likely present in all eukaryotic cells, that compartmentalize select signaling and functional events. Although it is difficult to place a lower limit on their size in the resting state, and evidence indeed exists for “lipid shells” surrounding individual proteins in biological membranes (2), rafts can also be driven to coalesce into more stable, micrometer-range domains through lipid–lipid, protein–lipid, and protein–protein interactions. The mechanisms underlying raft “coalescence” or “clustering,” however, in many cases remain elusive. It is generally thought that the saturated acyl chains of raft sphingolipids and phospholipids exhibit tight packing in a manner analogous to the liquid-ordered domains observed in model membranes, and that this may account for their resistance to solubilization by cold nonionic detergents (e.g., Triton X-100). However, as detergent can itself induce the formation of domains in membranes (6), rafts should not be equated with “detergent-resistant membranes” (DRMs), nor can identification of a protein in DRMs be taken as sufficient evidence for assigning raft localization in vivo. Although good evidence supports the coexistence within cell membranes of heterogeneous populations of lipid rafts, isolation of DRMs of discrete composition with the use of different detergents should not be considered as evidence for discrete raft domains in vivo.

Caveolae are ∼60- to 80-nm cholesterol-enriched membrane invaginations whose flask-shaped morphology derives from caveolin proteins, the expression of which suffices to confer caveolar morphology (7). Caveolae are thought to represent a discrete, specialized subpopulation of membrane microdomains, and thus should not be simply equated with lipid rafts. The caveolin proteins, through direct regulatory interactions with other proteins (e.g., TLR4) (8), are in particular thought to play a central role in signal regulation within caveolae. Of interest, although caveolae are well studied in certain cell types (e.g., endothelial cells, fibroblasts) and thought to be absent in others (e.g., lymphocytes), their presence in macrophages is less well defined and indeed controversial, varying by macrophage type (reviewed in Ref. 9).

Although rafts and/or caveolae promote immune receptor signaling in several pathways by serving as platforms for dynamic assembly of signaling complexes, in other cases, raft localization suppresses signaling (e.g., TGF-β and epidermal growth factor receptors) (1012). Moreover, in addition to concentrating signaling proteins, the lipid microenvironment of rafts may itself alter protein function (13), in some cases shaping signaling much more selectively than as just a simple binary switch. Thus, localization of the TNF receptor to raft versus non-raft domains determines responses to TNF-α, including cell fate as well as signaling events (14).

Protein localization to rafts, in many cases determined by GPI linkage or palmitoylation, is also thought to be responsive to raft cholesterol levels. Indeed, lipid-induced changes in the raft proteome likely explain reports, discussed below, that acute or chronic changes in raft cholesterol may determine protein signaling. Conversely, some proteins (e.g., NAP-22) and peptides (apolipoprotein [apo]A-I mimetic 4F) may themselves induce phase separation of cholesterol-rich and -poor domains (15) or induce raft signaling by deforming membrane lipids (16). Importantly, note that proteins, through scaffolding and other interactions, have been shown in some contexts to play dominant roles in determining membrane domains in immune cells (17, 18). Raft coalescence induced in dendritic cell membranes by physical contact of uric acid crystals (19), or in RAW 264.7 membranes by altered topography of the cell substratum (20), can also activate signaling proteins, including Syk and NF-κB. Taken together, these findings suggest that protein and lipid remodeling of the membrane interact to shape domains and cell signaling, and that raft signaling may be profoundly influenced or indeed induced by “ligand-independent” interventions upon plasma membrane lipid.

Interestingly, recent work indicates that the resting plasma membrane may be poised at the edge of a phase boundary such that simple membrane perturbations can drive large-scale phase separation of discrete protein/lipid macrodomains, thereby inducing signaling. Thus, crosslinking of the raft glycosphingolipid GM1 with cholera toxin B subunit induces cholesterol-dependent coalescence of micrometer-scale GM1 domains that recruit lipid-anchored raft proteins but exclude the non-raft transferrin receptor (21). Cholesterol depletion with methyl-β-cyclodextrin (mβCD) also induces micrometer-scale phase separation of the plasma membrane into fluid and ordered domains in living CHO cells (22), GM1-rich domains that concentrate Lck and LAT and signal to ERK activation in T cells (23), and GM1- and CD11b-rich domains in neutrophils (24). Imaging techniques with higher resolution than fluorescence microscopy will almost certainly be required to properly characterize raft colocalization and coalescence. Nonetheless, taken together, these findings confirm that membrane lipid remodeling is sufficient to drive cell signaling by reorganizing protein cargo, and they also demonstrate, perhaps paradoxically, that cholesterol depletion can increase membrane order and coalescence of raft-like domains, a topic to which we return below.

Notably, Ab-mediated crosslinking of several GPI-linked proteins can also coalesce/remodel rafts and induce signaling by copatching proteins within rafts. Crosslinking of external leaflet raft proteins induces copatching and activation of inner leaflet raft proteins such as H-ras (25), whereas crosslinking of GM1 can interestingly induce its copatching with TLR4 (26) and CD18 (27). As oligomeric cholesterol-binding cytolysins such as listeriolysin O both cluster CD14-rich rafts (28) and activate TLR4 (29), it seems plausible that some TLR4 agonists may activate this receptor through raft-mediated receptor clustering. In this light, it is important to remember that LPS, the canonical TLR4 ligand, is itself a polymeric molecule that induces receptor clustering.

Perhaps the most widely used experimental tools used to “disrupt” rafts are the β-cyclodextrins, mβCD and 2-hydroxyl-β-CD, cyclic oligosaccharides that remove cholesterol from membranes. Although numerous papers have used mβCD to infer that cell signals, including those induced by LPS, are raft-dependent, some caution is warranted (reviewed in Ref. 30). Thus, mβCD depletes cholesterol to varying degrees in different cell types, may under high concentrations (i.e., >10 mM) or prolonged incubations (>30 min) also remove extra-raft cholesterol or even cause cell death, and may interact with nonsterol lipids or immobilize membrane proteins through effects on the cytoskeleton (30). Moreover, mβCD and other in vitro manipulations of cell membrane lipid may not necessarily be physiologically relevant. These concerns notwithstanding, good evidence suggests that low concentration/short incubation usage of mβCD may be selective for raft cholesterol (3032). Moreover, multiple control strategies are available, including clamping of cell cholesterol with mβCD–cholesterol complexes, use of the structurally dissimilar cholesterol-sequestering agents filipin and nystatin, cholesterol depletion by lipoprotein-deficient serum, as well as additional raft-perturbing agents that have been described (Table I) (3346).

Table I.
Agents reported to disrupt raft structure and/or function and their associated effects on the cell
DisruptorCell TypeEffectReference
PUFAs EL4 cell ↓Raft coalescence, MHC I mislocalization 33  
HDL Monocyte ↓Raft chol, ↓CD11b activation 34  
4F MDM ↓Rafts, altered cell differentiation 35  
LXR agonists Prostate cancer cell ↓Raft size, ↓raft Akt phosphorylation 36  
SQS inhibitor Prostate cancer cell ↓Raft chol, ↓cell proliferation 37  
Statins NK cell ↓Membrane chol, ↓NK cell cytotoxicity 38  
oxLDL Endothelial ↓Raft chol, ↓raft eNOS, ↓eNOS activation 39  
oxPAPC Endothelial ↓LPS-induced raft TLR4, ↓LPS response 40  
Ceramide PBMC ↓Raft Lck, ↓raft PLD1, ↑PLD1 activity 41  
DPPE CD8+ T cell ↓MHC-induced raft proteins, ↓CTL activation 42  
DPPC, surfactant A549 ↓LPS-induced TLR4 translocation to rafts 43  
High glucose THP-1 ↓Number and size of caveolae 44  
Ethanol Mϕ ↓LPS-induced raft CD14 and TLR4 45  
ESeroS-GS Mϕ ↓LPS-induced raft CD14 and TLR4 46  
DisruptorCell TypeEffectReference
PUFAs EL4 cell ↓Raft coalescence, MHC I mislocalization 33  
HDL Monocyte ↓Raft chol, ↓CD11b activation 34  
4F MDM ↓Rafts, altered cell differentiation 35  
LXR agonists Prostate cancer cell ↓Raft size, ↓raft Akt phosphorylation 36  
SQS inhibitor Prostate cancer cell ↓Raft chol, ↓cell proliferation 37  
Statins NK cell ↓Membrane chol, ↓NK cell cytotoxicity 38  
oxLDL Endothelial ↓Raft chol, ↓raft eNOS, ↓eNOS activation 39  
oxPAPC Endothelial ↓LPS-induced raft TLR4, ↓LPS response 40  
Ceramide PBMC ↓Raft Lck, ↓raft PLD1, ↑PLD1 activity 41  
DPPE CD8+ T cell ↓MHC-induced raft proteins, ↓CTL activation 42  
DPPC, surfactant A549 ↓LPS-induced TLR4 translocation to rafts 43  
High glucose THP-1 ↓Number and size of caveolae 44  
Ethanol Mϕ ↓LPS-induced raft CD14 and TLR4 45  
ESeroS-GS Mϕ ↓LPS-induced raft CD14 and TLR4 46  

Selected examples are shown for each agent. Measures of raft disruption differ among reports. For some agents (e.g., ceramide), both raft stabilization and destabilization have been reported. For others (e.g., ethanol), inhibitory and stimulatory effects have been reported on the TLR4 pathway.

chol, cholesterol; DPPC, dipalmitoylphosphatidylcholine; DPPE, dipalmitoylphosphatidylethanolamine; 4F, apolipoprotein mimetic peptide 4F; LXR, liver X receptor; Mϕ, macrophage; MDM, monocyte-derived macrophage; oxPAPC, oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine; SQS, squalene synthase.

Although raft isolation and perturbation strategies have been used to show the requirement for raft integrity in several signaling pathways, a perhaps more intriguing chain of literature has shown that acute cholesterol depletion can itself initiate signaling cascades in a cell type-dependent fashion. CDs activate ERK in Rat-1 and RAW 264.7 cells (31, 47), p38 and Cdc42 in human neutrophils (48), and tyrosine phosphorylation in RBL-2H3 cells (49). mβCD and filipin initiate ligand-independent activation of epidermal growth factor receptor (10, 50) and Fas (51) by a mechanism involving displacement of these receptors from rafts. Conversely, cholesterol depletion may also cause a disintegrin and metalloproteinase domain-containing protein 10- and/or 17-dependent cleavage of several receptors (IL-6R, CD44, CD30, TNFR1, TNFR2) by causing their displacement from rafts (5255). mβCD also activates NF-κB in macrophages by a mechanism involving MyD88 (47). Consistent with these findings with CDs, we recently reported that the physiologic cholesterol acceptor apoA-I activates a TLR2-, TLR4-, and MyD88-dependent pathway to NF-κB in macrophages (47). Although the full significance of these assorted findings is not yet clear, and multiple underlying mechanisms are likely involved, taken together, these reports suggest that native microdomains of the cell membrane may serve to maintain signal quiescence by sequestering pathway components, and that their perturbation through cholesterol removal may induce pathways the nature of which is determined by the specific signaling proteins expressed in the cell under study.

Although it is now well recognized that pharmacologic raft-perturbing agents can modify raft-dependent signaling by delocalization of proteins, the effects of cholesterol loading on raft function under more physiologic settings are perhaps less widely appreciated. In primary murine macrophages, raft levels of TLR4 and TLR9, as well as cell responsiveness to TLR2, TLR4, TLR7, and TLR9 ligands, are all directly associated with exogenously manipulated raft cholesterol levels (56, 57). Moreover, hypercholesterolemia increases macrophage raft cholesterol in mice and humans in vivo, increasing cell responsiveness to LPS (58, 59). Perhaps more striking are reports that indicate that acute cholesterol loading of membranes may suffice to activate TLRs. Thus, cholesterol loading of the macrophage plasma membrane induces TLR4-dependent signaling, and loading of endosomal membranes induces TLR3- and TLR4-dependent responses (60). Conversely, it is also recognized that in other contexts (e.g., modified lipoprotein treatment) cholesterol loading can also be associated with reduced macrophage inflammatory function (61, 62). This may in part reflect the propensity of conditions to load cytosolic cholesterol ester instead of membrane cholesterol, as well as to activate nuclear receptors (e.g., liver X receptors, peroxisome proliferator-activated receptors).

Physiologically, raft/caveolar cholesterol content is regulated by homeostatic trafficking of cholesterol through the cell (Fig. 1), a topic covered in depth by recent comprehensive reviews (63). In brief, following cholesterol synthesis in the endoplasmic reticulum (ER) or endosomal recycling of internalized cholesterol to the ER/Golgi by Niemann–Pick C1 (NPC1) protein, it is thought that caveolae are assembled in the Golgi and transported to the plasma membrane in a caveolin- and NPC1-dependent fashion (7, 64). Thus, NPC-deficient fibroblasts have reduced plasma membrane caveolar cholesterol (64) and late endosomal cholesterol overload with raft overcrowding (65). Raft/caveolar cholesterol is, in turn, regulated by transporter-mediated (ATP-binding cassette [ABC]A1, ABCG1, and scavenger receptor [SR]-BI) efflux of plasma membrane cholesterol to extracellular acceptors, including lipid-free apoA-I and high-density lipoprotein (HDL), as well as by aqueous diffusion. Overexpression of ABCA1 (66) and treatment with HDL or apoA-I (67, 68) all disrupt/deplete raft domains, inhibiting raft-dependent signaling. The effect of stimulated cholesterol efflux is quite complex, however, as apoA-I, similar to mβCD, can enhance responses to some stimuli such as platelet-derived growth factor (68) by removing cholesterol from rafts (68, 69). Similarly, SR-BI–mediated cholesterol efflux to HDL activates endothelial NO synthase (eNOS) (70). Moreover, apoA-I may increase caveolar cholesterol by stimulating its transfer from intracellular compartments faster than its efflux (71).

FIGURE 1.

Intracellular cholesterol trafficking regulates macrophage rafts. Cholesterol synthesized in the ER by HMG-CoA reductase (HMGCR) or internalized via scavenger receptors (CD36, SR-A) or low-density lipoprotein receptor (LDLR) is assembled into nascent rafts in the Golgi apparatus for caveolin- and NPC1-dependent transfer to the plasma membrane. NPC1 together with NPC2 also regulates endosomal recycling of cholesterol to the plasma membrane. In turn, cholesterol is effluxed either by simple diffusion or via transporters (ABCA1, ABCG1, SR-BI) to extracellular acceptors (apoA-I, HDL), and also likely equilibrates with non-raft regions. Cholesterol esterification is regulated in the cytosol by cholesterol ester hydrolase (CEH) and in the ER by acyl-CoA:cholesterol acyltransferase 1 (ACAT1). Raft cholesterol/abundance and abundance of LPS recognition proteins (CD14, TLR4) are regulated by cholesterol flux through this pathway.

FIGURE 1.

Intracellular cholesterol trafficking regulates macrophage rafts. Cholesterol synthesized in the ER by HMG-CoA reductase (HMGCR) or internalized via scavenger receptors (CD36, SR-A) or low-density lipoprotein receptor (LDLR) is assembled into nascent rafts in the Golgi apparatus for caveolin- and NPC1-dependent transfer to the plasma membrane. NPC1 together with NPC2 also regulates endosomal recycling of cholesterol to the plasma membrane. In turn, cholesterol is effluxed either by simple diffusion or via transporters (ABCA1, ABCG1, SR-BI) to extracellular acceptors (apoA-I, HDL), and also likely equilibrates with non-raft regions. Cholesterol esterification is regulated in the cytosol by cholesterol ester hydrolase (CEH) and in the ER by acyl-CoA:cholesterol acyltransferase 1 (ACAT1). Raft cholesterol/abundance and abundance of LPS recognition proteins (CD14, TLR4) are regulated by cholesterol flux through this pathway.

Close modal

Building on earlier reports that TLR4 signaling occurs in lipid rafts (48), an exciting chain of literature has recently demonstrated profound effects of cholesterol trafficking through rafts on TLR signaling in the macrophage. ABCA1-null macrophages have enlarged, cholesterol-laden lipid rafts (56, 72) (Fig. 2) containing increased TLR4 (57), and they are hyperresponsive to LPS (56, 7274) as well as to TLR-2, -7, and -9 ligands (56, 74). ABCG1-null macrophages display a similar albeit perhaps more pronounced TLR-hyperresponsive phenotype (74, 75). NPC1-null macrophages display basal activation of TLR3, -7, -8, and -4 (60), the first three of which may reflect cholesterol overloading of endosomal rafts, and the last, TLR4 accumulation in endosomes due to blocked trafficking (76). Taken together, these reports indicate an intriguing degree of overlap between the pathway for trafficking of host lipids and that for recognition of microbial lipids, perhaps even suggesting common evolutionary roots between the two. Indeed, it was recently reported that, in addition to regulating efflux of cholesterol and phospholipid, ABCA1 also regulates efflux of LPS from the macrophage (77).

FIGURE 2.

ABCA1-deficient macrophages have enlarged lipid rafts. A, Rafts were imaged in peritoneal macrophages from wild-type (WT) and Abca1-null mice with the use of two raft cholesterol probes, BCθ toxin (red) and fluorescent polyethylene glycol cholesteryl ether (fPEG-chol) (green). Nuclei were stained with DAPI (blue). This research was originally published in the Journal of Lipid Research. Koseki, M., K. Hirano, D. Masuda, C. Ikegami, M. Tanaka, A. Ota, J. C. Sandoval, Y. Nakagawa-Toyama, S. B. Sato, T. Kobayashi, Y. Shimada, Y. Ohno-Iwashita, F. Matsuura, I. Shimomura, and S. Yamashita. Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-α secretion in Abca1-deficient macrophages. J. Lipid Res. 2007; 48:299–306. © the American Society for Biochemistry and Molecular Biology. B, Peritoneal macrophages from wild type (+/+) or macrophage-specific Abca1-null (-M/-M) mice were cholesterol depleted with mβCD or cholesterol loaded with mβCD-cholesterol, stained with fPEG-chol, and then quantified by flow cytometry. Data are means ± SEM. *p < 0.05, **p < 0.01. This research was originally published in the Journal of Lipid Research. Zhu, X., J. S. Owen, M. D. Wilson, H. Li, G. L. Griffiths, M. J. Thomas, E. M. Hiltbold, M. B. Fessler, and J. S. Parks. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J. Lipid Res. 2010; 51:3196–3206. © the American Society for Biochemistry and Molecular Biology.

FIGURE 2.

ABCA1-deficient macrophages have enlarged lipid rafts. A, Rafts were imaged in peritoneal macrophages from wild-type (WT) and Abca1-null mice with the use of two raft cholesterol probes, BCθ toxin (red) and fluorescent polyethylene glycol cholesteryl ether (fPEG-chol) (green). Nuclei were stained with DAPI (blue). This research was originally published in the Journal of Lipid Research. Koseki, M., K. Hirano, D. Masuda, C. Ikegami, M. Tanaka, A. Ota, J. C. Sandoval, Y. Nakagawa-Toyama, S. B. Sato, T. Kobayashi, Y. Shimada, Y. Ohno-Iwashita, F. Matsuura, I. Shimomura, and S. Yamashita. Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-α secretion in Abca1-deficient macrophages. J. Lipid Res. 2007; 48:299–306. © the American Society for Biochemistry and Molecular Biology. B, Peritoneal macrophages from wild type (+/+) or macrophage-specific Abca1-null (-M/-M) mice were cholesterol depleted with mβCD or cholesterol loaded with mβCD-cholesterol, stained with fPEG-chol, and then quantified by flow cytometry. Data are means ± SEM. *p < 0.05, **p < 0.01. This research was originally published in the Journal of Lipid Research. Zhu, X., J. S. Owen, M. D. Wilson, H. Li, G. L. Griffiths, M. J. Thomas, E. M. Hiltbold, M. B. Fessler, and J. S. Parks. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J. Lipid Res. 2010; 51:3196–3206. © the American Society for Biochemistry and Molecular Biology.

Close modal

Complex effects upon raft remodeling and signaling in TLR and other pathways have also been described for sphingomyelin and the product of its breakdown by sphingomyelinase, ceramide. Sphingomyelin and cholesterol promote raft formation in the Golgi via strong physical interactions (78), and ceramide indeed stabilizes rafts more effectively than does cholesterol (79). In contrast, good evidence indicates that sphingomyelinase treatment and ceramide itself both displace cholesterol from rafts (80, 81) in a manner that could realistically occur in vivo during inflammation. Indeed, acid sphingomyelinase-induced remodeling of the plasma membrane into enlarged ceramide-rich rafts during Pseudomonas aeruginosa infection is critical for bacterial internalization and for successful host defense (82). Interestingly, local acid sphingomyelinase-mediated ceramide production in rafts has also been reported to be required for LPS-induced recruitment of TLR4 to rafts (83), and ceramide itself elicits TLR4-dependent signaling (84). Although the full implications of these findings are not yet clear, it appears plausible that ceramide and cholesterol may “compete” to form somewhat distinct rafts, and that dynamic remodeling of raft lipid and protein composition by local ceramide induction may be a critical step in TLR signaling and perhaps other pathways.

Phospholipids have also been shown to modulate raft structure and function. Dipalmitoylphosphatidylethanolamine partitions into lipid rafts, inhibiting MHC peptide-induced raft recruitment of acylated proteins in CD8+ T cells (85) and TNF-induced recruitment of its receptor to rafts in HT1080 cells (14), without displaying overt effects on raft integrity. Similarly, the surfactant phospholipid dipalmitoylphosphatidylcholine and surfactant itself both attenuate LPS signaling by inhibiting TLR4 recruitment to rafts (43), perhaps suggesting that the lipid environment of the alveolus may dampen innate immune responses through effects on rafts. A role for phospholipid metabolism in cell-intrinsic TLR4 responses is also suggested by a report that lysophosphatidylcholine acyltransferase is required for LPS-induced translocation of TLR4 to rafts (85).

Oxidized lipids present during disease have been shown to modify rafts with associated effects on signaling. Thus, oxidized low-density lipoprotein (oxLDL) reduces caveolar cholesterol, displacing eNOS and caveolin (39). The major oxysterol in oxLDL, 7-ketocholesterol, partitions into rafts, depleting them of cholesterol (69) and activating Src within them (86). Oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine, a major oxidized phospholipid present in oxLDL, has also been shown to disrupt rafts through a mechanism involving ceramide induction, thereby inhibiting LPS-induced translocation of TLR4 to rafts (40, 87). Reports that reactive oxygen species are not only necessary but also sufficient to induce assembly of TCR-associated proteins in T cell rafts (88) and TLR4 trafficking to rafts in macrophages (26) suggest that oxidation of membrane lipids may also serve as a critical step in innate and adaptive immune signaling through raft remodeling. Indeed, an antioxidant α-tocopherol derivative has been shown to attenuate LPS signaling by interfering with CD14 and TLR4 recruitment to rafts (46).

Several strategies have shown early promise as potential therapeutic measures to modify raft signaling through intervening upon raft lipids. These include dietary polyunsaturated fatty acids (PUFAs), statins (i.e., 3-hydroxy-3-methyl-glutaryl-CoA [HMG-CoA] reductase inhibitors), squalene synthase inhibitors, raft-targeting lipids, and edelfosine. PUFAs such as docosahexaenoic acid and eicosapentaenoic acid inhibit signaling in Jurkat T cells by incorporating into rafts and displacing acylated signaling proteins (Lck, Fyn, LAT) (89). Alternatively, it has been proposed that PUFAs do not incorporate into rafts due to their unsaturation, but rather form extraraft domains that interfere indirectly with raft-dependent protein clustering (33, 90). Statins, increasingly studied for their anti-inflammatory actions, attenuate leukocyte function in part through membrane raft depletion (38). Inhibitors of squalene synthase, an enzyme downstream of HMG-CoA reductase in the cholesterol biosynthetic pathway, selectively reduce raft cholesterol in cancer cells and induce cell death (37). In an additional raft-centric strategy for cancer therapy, adhesion and cell cycle progression of breast cancer cells were recently shown to be more effectively inhibited by targeting a Src family kinase inhibitor to rafts through palmitoylation (91). Finally, a recent study has shown that the phospholipid ether edelfosine may be an effective therapeutic for multiple myeloma by accumulating in myeloma cell rafts, thereby inducing apoptosis through coclustering of rafts and death receptors (92). Taken together, these reports indicate the exciting potential to manipulate disease cells through several independent interventions that target raft lipids.

Many basic questions about the nature of rafts and caveolae remain unanswered, and many of these questions will almost certainly require high-resolution imaging techniques. Nonetheless, a convergence of independent approaches including biophysics, immunology, and lipid science has begun to indicate the fundamental importance of dynamic and chronic changes in membrane lipid to signaling in immune and other cells. Pathways for trafficking of cholesterol and other lipids through the macrophage, initially studied for their relevance to cell biology and metabolism, are now understood to be critical determinants of TLR signaling. At a basic level, these studies have also challenged the traditional paradigm of hierarchical protein signaling, showing that lateral changes in lipid domain segregation in the plasma membrane are not only necessary, but also sufficient to initiate protein signaling. A challenge for the field as it looks now to apply these insights to better understand “old” diseases and to develop new therapeutics will be to avoid conceptual constraint by the raft hypothesis itself.

We thank Sue Edelstein for assistance with figure design.

This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (Z01 ES102005) and by Grants HL094525 and HL049373 (to J.S.P.).

Abbreviations used in this article:

ABC

ATP-binding cassette

apo

apolipoprotein

DRM

detergent-resistant membrane

ER

endoplasmic reticulum

HDL

high-density lipoprotein

HMG-CoA

3-hydroxy-3-methyl-glutaryl-CoA

mβCD

methyl-β-cyclodextrin

NPC1

Niemann–Pick C1

oxLDL

oxidized low-density lipoprotein

PUFA

polyunsaturated fatty acid

SR

scavenger receptor.

1
Simons
K.
,
Ikonen
E.
.
1997
.
Functional rafts in cell membranes.
Nature
387
:
569
572
.
2
Jacobson
K.
,
Mouritsen
O. G.
,
Anderson
R. G.
.
2007
.
Lipid rafts: at a crossroad between cell biology and physics.
Nat. Cell Biol.
9
:
7
14
.
3
Simons
K.
,
Gerl
M. J.
.
2010
.
Revitalizing membrane rafts: new tools and insights.
Nat. Rev. Mol. Cell Biol.
11
:
688
699
.
4
Lingwood
D.
,
Simons
K.
.
2010
.
Lipid rafts as a membrane-organizing principle.
Science
327
:
46
50
.
5
Pike
L. J.
2009
.
The challenge of lipid rafts.
J. Lipid Res.
50
(
Suppl.
):
S323
S328
.
6
Heerklotz
H.
2002
.
Triton promotes domain formation in lipid raft mixtures.
Biophys. J.
83
:
2693
2701
.
7
Smart
E. J.
,
Ying
Y.
,
Donzell
W. C.
,
Anderson
R. G.
.
1996
.
A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane.
J. Biol. Chem.
271
:
29427
29435
.
8
Wang
X. M.
,
Kim
H. P.
,
Nakahira
K.
,
Ryter
S. W.
,
Choi
A. M.
.
2009
.
The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1.
J. Immunol.
182
:
3809
3818
.
9
Gargalovic
P.
,
Dory
L.
.
2003
.
Caveolins and macrophage lipid metabolism.
J. Lipid Res.
44
:
11
21
.
10
Chen
X.
,
Resh
M. D.
.
2002
.
Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor.
J. Biol. Chem.
277
:
49631
49637
.
11
Pike
L. J.
,
Casey
L.
.
2002
.
Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking.
Biochemistry
41
:
10315
10322
.
12
Chen
C. L.
,
Liu
I. H.
,
Fliesler
S. J.
,
Han
X.
,
Huang
S. S.
,
Huang
J. S.
.
2007
.
Cholesterol suppresses cellular TGF-β responsiveness: implications in atherogenesis.
J. Cell Sci.
120
:
3509
3521
.
13
Lee
A. G.
2004
.
How lipids affect the activities of integral membrane proteins.
Biochim. Biophys. Acta
1666
:
62
87
.
14
Legler
D. F.
,
Micheau
O.
,
Doucey
M. A.
,
Tschopp
J.
,
Bron
C.
.
2003
.
Recruitment of TNF receptor 1 to lipid rafts is essential for TNFα-mediated NF-κB activation.
Immunity
18
:
655
664
.
15
Epand
R. M.
2004
.
Do proteins facilitate the formation of cholesterol-rich domains?
Biochim. Biophys. Acta
1666
:
227
238
.
16
Min
C. K.
,
Bang
S. Y.
,
Cho
B. A.
,
Choi
Y. H.
,
Yang
J. S.
,
Lee
S. H.
,
Seong
S. Y.
,
Kim
K. W.
,
Kim
S.
,
Jung
J. U.
, et al
.
2008
.
Role of amphipathic helix of a herpesviral protein in membrane deformation and T cell receptor downregulation.
PLoS Pathog.
4
:
e1000209
.
17
Hashimoto-Tane
A.
,
Yokosuka
T.
,
Ishihara
C.
,
Sakuma
M.
,
Kobayashi
W.
,
Saito
T.
.
2010
.
T-cell receptor microclusters critical for T-cell activation are formed independently of lipid raft clustering.
Mol. Cell. Biol.
30
:
3421
3429
.
18
Harder
T.
,
Engelhardt
K. R.
.
2004
.
Membrane domains in lymphocytes: from lipid rafts to protein scaffolds.
Traffic
5
:
265
275
.
19
Ng
G.
,
Sharma
K.
,
Ward
S. M.
,
Desrosiers
M. D.
,
Stephens
L. A.
,
Schoel
W. M.
,
Li
T.
,
Lowell
C. A.
,
Ling
C. C.
,
Amrein
M. W.
,
Shi
Y.
.
2008
.
Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells.
Immunity
29
:
807
818
.
20
Waterfield
J. D.
,
Ali
T. A.
,
Nahid
F.
,
Kusano
K.
,
Brunette
D. M.
.
2010
.
The effect of surface topography on early NFκB signaling in macrophages.
J. Biomed. Mater. Res. A
95
:
837
847
.
21
Lingwood
D.
,
Ries
J.
,
Schwille
P.
,
Simons
K.
.
2008
.
Plasma membranes are poised for activation of raft phase coalescence at physiological temperature.
Proc. Natl. Acad. Sci. USA
105
:
10005
10010
.
22
Hao
M.
,
Mukherjee
S.
,
Maxfield
F. R.
.
2001
.
Cholesterol depletion induces large scale domain segregation in living cell membranes.
Proc. Natl. Acad. Sci. USA
98
:
13072
13077
.
23
Mahammad
S.
,
Dinic
J.
,
Adler
J.
,
Parmryd
I.
.
2010
.
Limited cholesterol depletion causes aggregation of plasma membrane lipid rafts inducing T cell activation.
Biochim. Biophys. Acta
1801
:
625
634
.
24
Solomkin
J. S.
,
Robinson
C. T.
,
Cave
C. M.
,
Ehmer
B.
,
Lentsch
A. B.
.
2007
.
Alterations in membrane cholesterol cause mobilization of lipid rafts from specific granules and prime human neutrophils for enhanced adherence-dependent oxidant production.
Shock
28
:
334
338
.
25
Eisenberg
S.
,
Shvartsman
D. E.
,
Ehrlich
M.
,
Henis
Y. I.
.
2006
.
Clustering of raft-associated proteins in the external membrane leaflet modulates internal leaflet H-ras diffusion and signaling.
Mol. Cell. Biol.
26
:
7190
7200
.
26
Nakahira
K.
,
Kim
H. P.
,
Geng
X. H.
,
Nakao
A.
,
Wang
X.
,
Murase
N.
,
Drain
P. F.
,
Wang
X.
,
Sasidhar
M.
,
Nabel
E. G.
, et al
.
2006
.
Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts.
J. Exp. Med.
203
:
2377
2389
.
27
Krauss
K.
,
Altevogt
P.
.
1999
.
Integrin leukocyte function-associated antigen-1-mediated cell binding can be activated by clustering of membrane rafts.
J. Biol. Chem.
274
:
36921
36927
.
28
Gekara
N. O.
,
Jacobs
T.
,
Chakraborty
T.
,
Weiss
S.
.
2005
.
The cholesterol-dependent cytolysin listeriolysin O aggregates rafts via oligomerization.
Cell. Microbiol.
7
:
1345
1356
.
29
Park
J. M.
,
Ng
V. H.
,
Maeda
S.
,
Rest
R. F.
,
Karin
M.
.
2004
.
Anthrolysin O and other Gram-positive cytolysins are Toll-like receptor 4 agonists.
J. Exp. Med.
200
:
1647
1655
.
30
Zidovetzki
R.
,
Levitan
I.
.
2007
.
Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies.
Biochim. Biophys. Acta
1768
:
1311
1324
.
31
Furuchi
T.
,
Anderson
R. G.
.
1998
.
Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK).
J. Biol. Chem.
273
:
21099
21104
.
32
Janes
P. W.
,
Ley
S. C.
,
Magee
A. I.
.
1999
.
Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor.
J. Cell Biol.
147
:
447
461
.
33
Shaikh
S. R.
,
Rockett
B. D.
,
Salameh
M.
,
Carraway
K.
.
2009
.
Docosahexaenoic acid modifies the clustering and size of lipid rafts and the lateral organization and surface expression of MHC class I of EL4 cells.
J. Nutr.
139
:
1632
1639
.
34
Murphy
A. J.
,
Woollard
K. J.
,
Hoang
A.
,
Mukhamedova
N.
,
Stirzaker
R. A.
,
McCormick
S. P.
,
Remaley
A. T.
,
Sviridov
D.
,
Chin-Dusting
J.
.
2008
.
High-density lipoprotein reduces the human monocyte inflammatory response.
Arterioscler. Thromb. Vasc. Biol.
28
:
2071
2077
.
35
Smythies
L. E.
,
White
C. R.
,
Maheshwari
A.
,
Palgunachari
M. N.
,
Anantharamaiah
G. M.
,
Chaddha
M.
,
Kurundkar
A. R.
,
Datta
G.
.
2010
.
Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages.
Am. J. Physiol. Cell Physiol.
298
:
C1538
C1548
.
36
Pommier
A. J.
,
Alves
G.
,
Viennois
E.
,
Bernard
S.
,
Communal
Y.
,
Sion
B.
,
Marceau
G.
,
Damon
C.
,
Mouzat
K.
,
Caira
F.
, et al
.
2010
.
Liver X receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells.
Oncogene
29
:
2712
2723
.
37
Brusselmans
K.
,
Timmermans
L.
,
Van de Sande
T.
,
Van Veldhoven
P. P.
,
Guan
G.
,
Shechter
I.
,
Claessens
F.
,
Verhoeven
G.
,
Swinnen
J. V.
.
2007
.
Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation.
J. Biol. Chem.
282
:
18777
18785
.
38
Hillyard
D. Z.
,
Nutt
C. D.
,
Thomson
J.
,
McDonald
K. J.
,
Wan
R. K.
,
Cameron
A. J.
,
Mark
P. B.
,
Jardine
A. G.
.
2007
.
Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation.
Atherosclerosis
191
:
319
325
.
39
Blair
A.
,
Shaul
P. W.
,
Yuhanna
I. S.
,
Conrad
P. A.
,
Smart
E. J.
.
1999
.
Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation.
J. Biol. Chem.
274
:
32512
32519
.
40
Walton
K. A.
,
Cole
A. L.
,
Yeh
M.
,
Subbanagounder
G.
,
Krutzik
S. R.
,
Modlin
R. L.
,
Lucas
R. M.
,
Nakai
J.
,
Smart
E. J.
,
Vora
D. K.
,
Berliner
J. A.
.
2003
.
Specific phospholipid oxidation products inhibit ligand activation of Toll-like receptors 4 and 2.
Arterioscler. Thromb. Vasc. Biol.
23
:
1197
1203
.
41
Diaz
O.
,
Mébarek-Azzam
S.
,
Benzaria
A.
,
Dubois
M.
,
Lagarde
M.
,
Némoz
G.
,
Prigent
A. F.
.
2005
.
Disruption of lipid rafts stimulates phospholipase d activity in human lymphocytes: implication in the regulation of immune function.
J. Immunol.
175
:
8077
8086
.
42
Legler
D. F.
,
Doucey
M. A.
,
Cerottini
J. C.
,
Bron
C.
,
Luescher
I. F.
.
2001
.
Selective inhibition of CTL activation by a dipalmitoyl-phospholipid that prevents the recruitment of signaling molecules to lipid rafts.
FASEB J.
15
:
1601
1603
.
43
Abate
W.
,
Alghaithy
A. A.
,
Parton
J.
,
Jones
K. P.
,
Jackson
S. K.
.
2010
.
Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains.
J. Lipid Res.
51
:
334
344
.
44
Hayashi
T.
,
Juliet
P. A.
,
Miyazaki
A.
,
Ignarro
L. J.
,
Iguchi
A.
.
2007
.
High glucose downregulates the number of caveolae in monocytes through oxidative stress from NADPH oxidase: implications for atherosclerosis.
Biochim. Biophys. Acta
1772
:
364
372
.
45
Dolganiuc
A.
,
Bakis
G.
,
Kodys
K.
,
Mandrekar
P.
,
Szabo
G.
.
2006
.
Acute ethanol treatment modulates Toll-like receptor-4 association with lipid rafts.
Alcohol. Clin. Exp. Res.
30
:
76
85
.
46
Duan
W.
,
Zhou
J.
,
Zhang
S.
,
Zhao
K.
,
Zhao
L.
,
Ogata
K.
,
Sakaue
T.
,
Mori
A.
,
Wei
T.
.
2011
.
ESeroS-GS modulates lipopolysaccharide-induced macrophage activation by impairing the assembly of TLR-4 complexes in lipid rafts.
Biochim. Biophys. Acta
1813
:
772
783
.
47
Smoak
K. A.
,
Aloor
J. J.
,
Madenspacher
J.
,
Merrick
B. A.
,
Collins
J. B.
,
Zhu
X.
,
Cavigiolio
G.
,
Oda
M. N.
,
Parks
J. S.
,
Fessler
M. B.
.
2010
.
Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation.
Cell Metab.
11
:
493
502
.
48
Fessler
M. B.
,
Arndt
P. G.
,
Frasch
S. C.
,
Lieber
J. G.
,
Johnson
C. A.
,
Murphy
R. C.
,
Nick
J. A.
,
Bratton
D. L.
,
Malcolm
K. C.
,
Worthen
G. S.
.
2004
.
Lipid rafts regulate lipopolysaccharide-induced activation of Cdc42 and inflammatory functions of the human neutrophil.
J. Biol. Chem.
279
:
39989
39998
.
49
Surviladze
Z.
,
Dráberová
L.
,
Kovárová
M.
,
Boubelík
M.
,
Dráber
P.
.
2001
.
Differential sensitivity to acute cholesterol lowering of activation mediated via the high-affinity IgE receptor and Thy-1 glycoprotein.
Eur. J. Immunol.
31
:
1
10
.
50
Lambert
S.
,
Vind-Kezunovic
D.
,
Karvinen
S.
,
Gniadecki
R.
.
2006
.
Ligand-independent activation of the EGFR by lipid raft disruption.
J. Invest. Dermatol.
126
:
954
962
.
51
Gniadecki
R.
2004
.
Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis.
Biochem. Biophys. Res. Commun.
320
:
165
169
.
52
Matthews
V.
,
Schuster
B.
,
Schütze
S.
,
Bussmeyer
I.
,
Ludwig
A.
,
Hundhausen
C.
,
Sadowski
T.
,
Saftig
P.
,
Hartmann
D.
,
Kallen
K. J.
,
Rose-John
S.
.
2003
.
Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE).
J. Biol. Chem.
278
:
38829
38839
.
53
Murai
T.
,
Maruyama
Y.
,
Mio
K.
,
Nishiyama
H.
,
Suga
M.
,
Sato
C.
.
2011
.
Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration.
J. Biol. Chem.
286
:
1999
2007
.
54
von Tresckow
B.
,
Kallen
K. J.
,
von Strandmann
E. P.
,
Borchmann
P.
,
Lange
H.
,
Engert
A.
,
Hansen
H. P.
.
2004
.
Depletion of cellular cholesterol and lipid rafts increases shedding of CD30.
J. Immunol.
172
:
4324
4331
.
55
Tellier
E.
,
Canault
M.
,
Poggi
M.
,
Bonardo
B.
,
Nicolay
A.
,
Alessi
M. C.
,
Nalbone
G.
,
Peiretti
F.
.
2008
.
HDLs activate ADAM17-dependent shedding.
J. Cell. Physiol.
214
:
687
693
.
56
Zhu
X.
,
Lee
J. Y.
,
Timmins
J. M.
,
Brown
J. M.
,
Boudyguina
E.
,
Mulya
A.
,
Gebre
A. K.
,
Willingham
M. C.
,
Hiltbold
E. M.
,
Mishra
N.
, et al
.
2008
.
Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages.
J. Biol. Chem.
283
:
22930
22941
.
57
Zhu
X.
,
Owen
J. S.
,
Wilson
M. D.
,
Li
H.
,
Griffiths
G. L.
,
Thomas
M. J.
,
Hiltbold
E. M.
,
Fessler
M. B.
,
Parks
J. S.
.
2010
.
Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol.
J. Lipid Res.
51
:
3196
3206
.
58
Madenspacher
J. H.
,
Draper
D. W.
,
Smoak
K. A.
,
Li
H.
,
Griffiths
G. L.
,
Suratt
B. T.
,
Wilson
M. D.
,
Rudel
L. L.
,
Fessler
M. B.
.
2010
.
Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes.
J. Immunol.
185
:
1660
1669
.
59
Oiknine
J.
,
Aviram
M.
.
1992
.
Increased susceptibility to activation and increased uptake of low density lipoprotein by cholesterol-loaded macrophages.
Arterioscler. Thromb.
12
:
745
753
.
60
Sun
Y.
,
Ishibashi
M.
,
Seimon
T.
,
Lee
M.
,
Sharma
S. M.
,
Fitzgerald
K. A.
,
Samokhin
A. O.
,
Wang
Y.
,
Sayers
S.
,
Aikawa
M.
, et al
.
2009
.
Free cholesterol accumulation in macrophage membranes activates Toll-like receptors and p38 mitogen-activated protein kinase and induces cathepsin K.
Circ. Res.
104
:
455
465
.
61
Hamilton
T. A.
,
Ma
G. P.
,
Chisolm
G. M.
.
1990
.
Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-α mRNA in stimulated murine peritoneal macrophages.
J. Immunol.
144
:
2343
2350
.
62
Haga
Y.
,
Takata
K.
,
Araki
N.
,
Sakamoto
K.
,
Akagi
M.
,
Morino
Y.
,
Horiuchi
S.
.
1989
.
Intracellular accumulation of cholesteryl esters suppresses production of lipopolysaccharide-induced interleukin 1 by rat peritoneal macrophages.
Biochem. Biophys. Res. Commun.
160
:
874
880
.
63
Ikonen
E.
2008
.
Cellular cholesterol trafficking and compartmentalization.
Nat. Rev. Mol. Cell Biol.
9
:
125
138
.
64
Garver
W. S.
,
Krishnan
K.
,
Gallagos
J. R.
,
Michikawa
M.
,
Francis
G. A.
,
Heidenreich
R. A.
.
2002
.
Niemann-Pick C1 protein regulates cholesterol transport to the trans-Golgi network and plasma membrane caveolae.
J. Lipid Res.
43
:
579
589
.
65
Lusa
S.
,
Blom
T. S.
,
Eskelinen
E. L.
,
Kuismanen
E.
,
Månsson
J. E.
,
Simons
K.
,
Ikonen
E.
.
2001
.
Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane.
J. Cell Sci.
114
:
1893
1900
.
66
Landry
Y. D.
,
Denis
M.
,
Nandi
S.
,
Bell
S.
,
Vaughan
A. M.
,
Zha
X.
.
2006
.
ATP-binding cassette transporter A1 expression disrupts raft membrane microdomains through its ATPase-related functions.
J. Biol. Chem.
281
:
36091
36101
.
67
Peshavariya
H.
,
Dusting
G. J.
,
Di Bartolo
B.
,
Rye
K. A.
,
Barter
P. J.
,
Jiang
F.
.
2009
.
Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts.
Free Radic. Res.
43
:
772
782
.
68
Fielding
P. E.
,
Russel
J. S.
,
Spencer
T. A.
,
Hakamata
H.
,
Nagao
K.
,
Fielding
C. J.
.
2002
.
Sterol efflux to apolipoprotein A-I originates from caveolin-rich microdomains and potentiates PDGF-dependent protein kinase activity.
Biochemistry
41
:
4929
4937
.
69
Gaus
K.
,
Kritharides
L.
,
Schmitz
G.
,
Boettcher
A.
,
Drobnik
W.
,
Langmann
T.
,
Quinn
C. M.
,
Death
A.
,
Dean
R. T.
,
Jessup
W.
.
2004
.
Apolipoprotein A-1 interaction with plasma membrane lipid rafts controls cholesterol export from macrophages.
FASEB J.
18
:
574
576
.
70
Assanasen
C.
,
Mineo
C.
,
Seetharam
D.
,
Yuhanna
I. S.
,
Marcel
Y. L.
,
Connelly
M. A.
,
Williams
D. L.
,
de la Llera-Moya
M.
,
Shaul
P. W.
,
Silver
D. L.
.
2005
.
Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling.
J. Clin. Invest.
115
:
969
977
.
71
Sviridov
D.
,
Fidge
N.
,
Beaumier-Gallon
G.
,
Fielding
C.
.
2001
.
Apolipoprotein A-I stimulates the transport of intracellular cholesterol to cell-surface cholesterol-rich domains (caveolae).
Biochem. J.
358
:
79
86
.
72
Koseki
M.
,
Hirano
K.
,
Masuda
D.
,
Ikegami
C.
,
Tanaka
M.
,
Ota
A.
,
Sandoval
J. C.
,
Nakagawa-Toyama
Y.
,
Sato
S. B.
,
Kobayashi
T.
, et al
.
2007
.
Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-α secretion in Abca1-deficient macrophages.
J. Lipid Res.
48
:
299
306
.
73
Francone
O. L.
,
Royer
L.
,
Boucher
G.
,
Haghpassand
M.
,
Freeman
A.
,
Brees
D.
,
Aiello
R. J.
.
2005
.
Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophages.
Arterioscler. Thromb. Vasc. Biol.
25
:
1198
1205
.
74
Yvan-Charvet
L.
,
Welch
C.
,
Pagler
T. A.
,
Ranalletta
M.
,
Lamkanfi
M.
,
Han
S.
,
Ishibashi
M.
,
Li
R.
,
Wang
N.
,
Tall
A. R.
.
2008
.
Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions.
Circulation
118
:
1837
1847
.
75
Draper
D. W.
,
Madenspacher
J. H.
,
Dixon
D.
,
King
D. H.
,
Remaley
A. T.
,
Fessler
M. B.
.
2010
.
ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung.
Am. J. Respir. Crit. Care Med.
182
:
404
412
.
76
Suzuki
M.
,
Sugimoto
Y.
,
Ohsaki
Y.
,
Ueno
M.
,
Kato
S.
,
Kitamura
Y.
,
Hosokawa
H.
,
Davies
J. P.
,
Ioannou
Y. A.
,
Vanier
M. T.
, et al
.
2007
.
Endosomal accumulation of Toll-like receptor 4 causes constitutive secretion of cytokines and activation of signal transducers and activators of transcription in Niemann-Pick disease type C (NPC) fibroblasts: a potential basis for glial cell activation in the NPC brain.
J. Neurosci.
27
:
1879
1891
.
77
Thompson
P. A.
,
Gauthier
K. C.
,
Varley
A. W.
,
Kitchens
R. L.
.
2010
.
ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance.
J. Lipid Res.
51
:
2672
2685
.
78
Van der Luit
A. H.
,
Budde
M.
,
Zerp
S.
,
Caan
W.
,
Klarenbeek
J. B.
,
Verheij
M.
,
Van Blitterswijk
W. J.
.
2007
.
Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin- and cholesterol-deficiency in lipid rafts.
Biochem. J.
401
:
541
549
.
79
Xu
X.
,
Bittman
R.
,
Duportail
G.
,
Heissler
D.
,
Vilcheze
C.
,
London
E.
.
2001
.
Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts): comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of sphingomyelin, cerebrosides, and ceramide.
J. Biol. Chem.
276
:
33540
33546
.
80
Megha
,
London
E.
.
2004
.
Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function.
J. Biol. Chem.
279
:
9997
10004
.
81
Yu
C.
,
Alterman
M.
,
Dobrowsky
R. T.
.
2005
.
Ceramide displaces cholesterol from lipid rafts and decreases the association of the cholesterol binding protein caveolin-1.
J. Lipid Res.
46
:
1678
1691
.
82
Grassmé
H.
,
Jendrossek
V.
,
Riehle
A.
,
von Kürthy
G.
,
Berger
J.
,
Schwarz
H.
,
Weller
M.
,
Kolesnick
R.
,
Gulbins
E.
.
2003
.
Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts.
Nat. Med.
9
:
322
330
.
83
Cuschieri
J.
,
Bulger
E.
,
Billgrin
J.
,
Garcia
I.
,
Maier
R. V.
.
2007
.
Acid sphingomyelinase is required for lipid raft TLR4 complex formation.
Surg. Infect. (Larchmt)
8
:
91
106
.
84
Fischer
H.
,
Ellström
P.
,
Ekström
K.
,
Gustafsson
L.
,
Gustafsson
M.
,
Svanborg
C.
.
2007
.
Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4.
Cell. Microbiol.
9
:
1239
1251
.
85
Jackson
S. K.
,
Abate
W.
,
Parton
J.
,
Jones
S.
,
Harwood
J. L.
.
2008
.
Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response.
J. Leukoc. Biol.
84
:
86
92
.
86
Myers
S. J.
,
Stanley
K. K.
.
1999
.
Src family kinase activation in glycosphingolipid-rich membrane domains of endothelial cells treated with oxidised low density lipoprotein.
Atherosclerosis
143
:
389
397
.
87
Walton
K. A.
,
Gugiu
B. G.
,
Thomas
M.
,
Basseri
R. J.
,
Eliav
D. R.
,
Salomon
R. G.
,
Berliner
J. A.
.
2006
.
A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products.
J. Lipid Res.
47
:
1967
1974
.
88
Lu
S. P.
,
Lin Feng
M. H.
,
Huang
H. L.
,
Huang
Y. C.
,
Tsou
W. I.
,
Lai
M. Z.
.
2007
.
Reactive oxygen species promote raft formation in T lymphocytes.
Free Radic. Biol. Med.
42
:
936
944
.
89
Stulnig
T. M.
,
Berger
M.
,
Sigmund
T.
,
Raederstorff
D.
,
Stockinger
H.
,
Waldhäusl
W.
.
1998
.
Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains.
J. Cell Biol.
143
:
637
644
.
90
Wassall
S. R.
,
Stillwell
W.
.
2008
.
Docosahexaenoic acid domains: the ultimate non-raft membrane domain.
Chem. Phys. Lipids
153
:
57
63
.
91
Hitosugi
T.
,
Sato
M.
,
Sasaki
K.
,
Umezawa
Y.
.
2007
.
Lipid raft specific knockdown of SRC family kinase activity inhibits cell adhesion and cell cycle progression of breast cancer cells.
Cancer Res.
67
:
8139
8148
.
92
Mollinedo
F.
,
de la Iglesia-Vicente
J.
,
Gajate
C.
,
Estella-Hermoso de Mendoza
A.
,
Villa-Pulgarin
J. A.
,
Campanero
M. A.
,
Blanco-Prieto
M. J.
.
2010
.
Lipid raft-targeted therapy in multiple myeloma.
Oncogene
29
:
3748
3757
.

The authors have no financial conflicts of interest.